Omicron News and Research

RSS
High mutation count in new COVID-19 variants does not increase immune evasion, study finds

High mutation count in new COVID-19 variants does not increase immune evasion, study finds

Vaccines and virus changes cut long COVID risk by 50%, but Omicron still poses a threat

Vaccines and virus changes cut long COVID risk by 50%, but Omicron still poses a threat

Study offers insights on prevalence and risk factors of persistent post-COVID-19 symptoms

Study offers insights on prevalence and risk factors of persistent post-COVID-19 symptoms

Digital contact tracing data reveals detailed epidemic patterns in England and Wales

Digital contact tracing data reveals detailed epidemic patterns in England and Wales

Frequent infections and pathobionts boost children's nasal immunity, study reveals

Frequent infections and pathobionts boost children's nasal immunity, study reveals

Regular booster doses of bivalent mRNA COVID-19 vaccines help neutralize multiple strains

Regular booster doses of bivalent mRNA COVID-19 vaccines help neutralize multiple strains

NIH launches Phase 1 trial for innovative nasal COVID-19 vaccine

NIH launches Phase 1 trial for innovative nasal COVID-19 vaccine

Low-cost CRISPR-based paper strip test offers rapid influenza diagnosis

Low-cost CRISPR-based paper strip test offers rapid influenza diagnosis

Study shows vaccines cut long COVID risk, especially for those with preexisting conditions

Study shows vaccines cut long COVID risk, especially for those with preexisting conditions

New research on long COVID prevalence and risk factors

New research on long COVID prevalence and risk factors

At-home antibody tests could drive higher COVID-19 booster rates, new research finds

At-home antibody tests could drive higher COVID-19 booster rates, new research finds

N95 respirators potential standard of care in nursing homes and healthcare settings during respiratory viral infections

N95 respirators potential standard of care in nursing homes and healthcare settings during respiratory viral infections

TMPRSS2 protein facilitates SARS-CoV-2 entry via unexpected pathway

TMPRSS2 protein facilitates SARS-CoV-2 entry via unexpected pathway

Three-year study shows lingering effects of COVID-19

Three-year study shows lingering effects of COVID-19

Inexpensive “duckbill” N95 becomes the champion in COVID-19 mask effectiveness

Inexpensive “duckbill” N95 becomes the champion in COVID-19 mask effectiveness

COVID-19 boosters targeting omicron subvariants remain effective, but wane over time

COVID-19 boosters targeting omicron subvariants remain effective, but wane over time

New antibody shows promise as universal weapon against COVID-19 variants

New antibody shows promise as universal weapon against COVID-19 variants

100-year-old BCG vaccine protects individuals with type 1 diabetes from infectious diseases

100-year-old BCG vaccine protects individuals with type 1 diabetes from infectious diseases

LVRNA009 mRNA vaccine shows long-term efficacy against SARS-CoV-2 variants

LVRNA009 mRNA vaccine shows long-term efficacy against SARS-CoV-2 variants

Study reveals positive impact of repeat COVID-19 vaccinations

Study reveals positive impact of repeat COVID-19 vaccinations

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.